Age <60 | Age 60–69 | Age 70–79 | Age 80+ | All ages | |
---|---|---|---|---|---|
Total (n) | 710 | 848 | 694 | 128 | 2380 |
Alive at 1 year (n) | 219 | 219 | 146 | 14 | 598 |
Relative 1 year survival (%) | 31% | 26% | 22% | 13% | 26% |
Overall 1 year survival (%) and univariate p values | Multivariable | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
% | p value | % | p value | % | p value | % | p value | HR | p value | |
HR = hazard ratio for death; RT = radiotherapy. | ||||||||||
*Stage III or IV. | ||||||||||
†Reference category. | ||||||||||
Age | ||||||||||
<60 | 31 | 0.93 | 0.2 | |||||||
60–69† | 26 | 1 | ||||||||
70–79 | 21 | 1.05 | 0.3 | |||||||
80+ | 11 | 1.14 | 0.2 | |||||||
Sex | ||||||||||
Female‡ | 32 | 20 | 11 | 14 | 1 | |||||
Male | 30 | 0.6 | 27 | 0.08 | 23 | 0.06 | 10 | 0.9 | 1.04 | 0.5 |
Histology | ||||||||||
Squamous cell‡ | 35 | 29 | 28 | 12 | 1 | |||||
Adenocarcinoma | 28 | 28 | 18 | 13 | 1.07 | 0.2 | ||||
Large cell undifferentiated | 29 | 0.3 | 20 | 0.08 | 14 | 0.01 | 8 | 0.6 | 1.03 | 0.6 |
Stage | ||||||||||
III‡ | 41 | 35 | 28 | 13 | 1 | |||||
IV | 19 | <0.001 | 13 | <0.001 | 10 | <0.001 | 9 | 0.7 | 1.14 | 0.01 |
Comorbidity | ||||||||||
0‡ | 31 | 25 | 23 | – | 1 | |||||
1 | 31 | 29 | 22 | – | 1.01 | 0.8 | ||||
2+ | 25 | 0.4 | 25 | 0.6 | 19 | 0.5 | – | 1.05 | 0.4 | |
Treatment | ||||||||||
RT‡ | 28 | 29 | 28 | – | 1 | |||||
Surgery (±RT) | 55 | 49 | 37 | – | 0.69 | <0.001 | ||||
Chemo (±RT) | 39 | 35 | 38 | – | 0.90 | 0.2 | ||||
Other/none | 9 | <0.001 | 8 | <0.001 | 8 | <0.001 | – | 1.13 | 0.03 |